扶正口服液治疗癌症恶病质的临床观察
发布时间:2018-09-06 13:05
【摘要】:目的:观察扶正口服液治疗癌症恶病质的临床疗效。方法:将60例癌症恶病质患者随机分为治疗组和对照组各30例,对照组予甲地孕酮治疗,治疗组在对照组基础上予扶正口服液口服,比较两组患者治疗前后体质量、进食量、KPS评分及蛋白的变化。结果:治疗组在进食量、体质量及KPS评分方面,疗效均优于对照组(P0.05)。治疗组治疗后血红蛋白、血清白蛋白均高于治疗前,且高于对照组治疗后(P0.05)。结论:扶正口服液可增加癌症恶病质的体质量、进食量,提高KPS评分,且可提高血红蛋白及血清白蛋白,对癌症恶病质的治疗具有积极作用。
[Abstract]:Objective: to observe the clinical effect of Fuzheng oral liquid on cancer cachexia. Methods: sixty patients with cancer cachexia were randomly divided into treatment group (n = 30) and control group (n = 30). The control group was treated with megestrol and the treatment group was treated with Fuzheng oral liquid on the basis of the control group. The body mass of the two groups was compared before and after treatment. Changes of KPS score and protein. Results: the therapeutic effect of the treatment group was better than that of the control group in food intake, body mass and KPS score (P0.05). The levels of hemoglobin and serum albumin in the treatment group were higher than those before treatment and higher than those in the control group (P0.05). Conclusion: Fuzheng oral liquid can increase the body weight of cancer cachexia, food intake, KPS score, hemoglobin and serum albumin, and play an active role in the treatment of cancer cachexia.
【作者单位】: 湖南中医药大学;湖南中医药大学第一附属医院;
【分类号】:R273
本文编号:2226437
[Abstract]:Objective: to observe the clinical effect of Fuzheng oral liquid on cancer cachexia. Methods: sixty patients with cancer cachexia were randomly divided into treatment group (n = 30) and control group (n = 30). The control group was treated with megestrol and the treatment group was treated with Fuzheng oral liquid on the basis of the control group. The body mass of the two groups was compared before and after treatment. Changes of KPS score and protein. Results: the therapeutic effect of the treatment group was better than that of the control group in food intake, body mass and KPS score (P0.05). The levels of hemoglobin and serum albumin in the treatment group were higher than those before treatment and higher than those in the control group (P0.05). Conclusion: Fuzheng oral liquid can increase the body weight of cancer cachexia, food intake, KPS score, hemoglobin and serum albumin, and play an active role in the treatment of cancer cachexia.
【作者单位】: 湖南中医药大学;湖南中医药大学第一附属医院;
【分类号】:R273
【相似文献】
相关期刊论文 前6条
1 刘华;缪莉娟;;扶正口服液对气血两虚型晚期癌症患者生活质量的影响[J];中医药导报;2013年03期
2 曹正柳;益生扶正口服液治疗脾虚证临床分析[J];江西中医药;1995年S3期
3 何健飞,黄景贤,苏贞栋,黄海平;贞芪扶正口服液防治化疗毒副反应40例[J];辽宁中医学院学报;2001年03期
4 何健飞;吴雪峰;杨华;何晓洪;冯燕妮;;贞芪扶正口服液治疗恶性肿瘤放化疗后脾肾亏虚证临床观察[J];山东中医杂志;2007年05期
5 刘华;李杳瑶;王理槐;;扶正口服液防治伽玛刀治疗原发性肝癌毒副反应临床观察[J];中国中医药信息杂志;2013年10期
6 ;[J];;年期
,本文编号:2226437
本文链接:https://www.wllwen.com/zhongyixuelunwen/2226437.html
最近更新
教材专著